E-LIB Suche - Ergebnisse für: Viqueira, Joaquin A.

1

Modulating the DNA cleavage ability of copper(ii) Schiff ba..:

Viqueira, Joaquín ; Durán, María L. ; García-Vázquez, José A....
New Journal of Chemistry. 42 (2018) 18 - p. 15170-15183 , 2018

Link: https://doi.org/10.1039/..

2

Structural studies and bioactivity of diorganotin(IV) compl..:

Barreiro, Sara ; Durán-Carril, María L. ; Viqueira, Joaquín...
Journal of Organometallic Chemistry. 791 (2015) - p. 155-162 , 2015

Link: https://doi.org/10.1016/..

3

Electrochemical synthesis and structural characterization o..:

Casanova, Isabel ; Sousa-Pedrares, Antonio ; Viqueira, Joaquin...
New Journal of Chemistry. 37 (2013) 8 - p. 2303 , 2013

Link: https://doi.org/10.1039/..

4

Synthesis and Characterization of Homoleptic and Heterolept..:

Sousa‐Pedrares, Antonio ; Viqueira, Joaquin A. ; Antelo, Jorge...
European Journal of Inorganic Chemistry. 2011 (2011) 14 - p. 2273-2287 , 2011

Link: https://doi.org/10.1002/..

5

Long‐term survival and safety of elranatamab in patients wi..:

Tomasson, Michael H. ; Iida, Shinsuke ; Niesvizky, Ruben...
HemaSphere. 8 (2024) 7 - p. , 2024

Link: https://doi.org/10.1002/..

6

POSTER: MM-364 Elranatamab, a B-Cell Maturation Antigen (BC..:

Mohty, Mohamad ; Tomasson, Michael H. ; Arnulf, Bertrand...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S225 , 2023

Link: https://doi.org/10.1016/..

7

Elranatamab in relapsed or refractory multiple myeloma: pha..:

Lesokhin, Alexander M. ; Tomasson, Michael H. ; Arnulf, Bertrand...
Nature Medicine. 29 (2023) 9 - p. 2259-2267 , 2023

Link: https://doi.org/10.1038/..

8

S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 B..:

Mohty, Mohamad ; Tomasson, Michael H. ; Arnulf, Bertrand...
HemaSphere. 7 (2023) S3 - p. e1309654 , 2023

Link: https://doi.org/10.1097/..

9

MM-364 Elranatamab, a B-Cell Maturation Antigen (BCMA)-CD3 ..:

Mohty, Mohamad ; Tomasson, Michael H. ; Arnulf, Bertrand...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S493-S494 , 2023

Link: https://doi.org/10.1016/..

10

Elranatamab in relapsed or refractory multiple myeloma: pha..:

Lesokhin, Alexander M ; Tomasson, Michael H ; Arnulf, Bertrand...
boreal:277666. , 2023

Link: http://hdl.handle.net/20..

11

Elranatamab in relapsed or refractory multiple myeloma: pha..:

Lesokhin, Alexander M ; Tomasson, Michael H ; Arnulf, Bertrand...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504075/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Elranatamab in relapsed or refractory multiple myeloma: pha..:

Lesokhin, Alexander M ; Tomasson, Michael H ; Arnulf, Bertrand...
boreal:277666. , 2023

Link: http://hdl.handle.net/20..

13

S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 B..:

Mohty, Mohamad ; Tomasson, Michael H ; Arnulf, Bertrand...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428276/. , 2023

Link: http://www.ncbi.nlm.nih...

14

Byko-Spectra effect light booth simulation for digital rend..:

Huraibat, Khalil ; Perales, Esther ; Viqueira, V...
#PLACEHOLDER_PARENT_METADATA_VALUE#. , 2019

Link: http://hdl.handle.net/10..

15

Byko-Spectra effect light booth simulation for digital rend..:

Huraibat, Khalil ; Perales, Esther ; Viqueira, V...
Sí. , 2019

Link: http://hdl.handle.net/10..